111 related articles for article (PubMed ID: 7535445)
1. Is CD33 a differentiation marker?
Fritsch G; Buchinger P; Printz D; Dworzak MD; Strunk S; Agis H; Sliutz G; Wilfing A; Schulz U; Gadner H
Prog Clin Biol Res; 1994; 389():377-82. PubMed ID: 7535445
[No Abstract] [Full Text] [Related]
2. Comparative analysis of peripheral stem cells collected and transplanted in combination with granulocyte-macrophage and granulocyte colony-stimulating factors.
Handgretinger R; Klingebiel T; Herter M; Lang P; Gisselhart A; Dopfer R; Scheel-Walter H; Ehrlich H; Niethammer D
Prog Clin Biol Res; 1994; 389():479-86. PubMed ID: 7535457
[No Abstract] [Full Text] [Related]
3. Kinetics of low and high dose granulocyte/macrophage colony stimulating factor mobilization of peripheral blood stem cells.
Jackson JD; Letheby B; O'Kane Murphy B; Costas P; Wang PN; Bishop MR; Kessinger A; Warkentin PI
Prog Clin Biol Res; 1994; 389():471-7. PubMed ID: 7535456
[No Abstract] [Full Text] [Related]
4. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
[TBL] [Abstract][Full Text] [Related]
5. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
[TBL] [Abstract][Full Text] [Related]
6. Comparison of three mobilization regimens for peripheral blood progenitor cell rescue after high dose chemotherapy.
Lee WJ; Zimmerman T; Meyers S; Bender JG; Williams SF
Prog Clin Biol Res; 1994; 389():421-7. PubMed ID: 7535451
[No Abstract] [Full Text] [Related]
7. Characterization of enriched CD34+ cells from healthy volunteers and those from patients treated with chemotherapy plus granulocyte colony-stimulating factor (G-CSF).
Suzuki T; Muroi K; Tomizuka H; Amemiya Y; Miura Y
Stem Cells; 1995 May; 13(3):273-80. PubMed ID: 7542113
[TBL] [Abstract][Full Text] [Related]
8. CD34 analysis in erythropoietin mobilized peripheral blood stem cells.
O'Kane-Murphy B; Jackson JD; Kuszynski C; Costas P; Wang PN; Warkentin PI; Kessinger A
Prog Clin Biol Res; 1994; 389():371-6. PubMed ID: 7535444
[No Abstract] [Full Text] [Related]
9. Expansion of cord blood progenitors and use for hemopoietic reconstitution.
Gabutti V; Timeus F; Ramenghi U; Crescenzio N; Marranca D; Miniero R; Cornaglia G; Bagnara GP
Stem Cells; 1993 Jul; 11 Suppl 2():105-12. PubMed ID: 7691315
[TBL] [Abstract][Full Text] [Related]
10. CD34 analysis in peripheral blood correlates with colony forming capacity--an update.
Fritsch G; Emminger W; Buchinger P; Printz D; Gadner H
Prog Clin Biol Res; 1992; 377():531-6. PubMed ID: 1279721
[No Abstract] [Full Text] [Related]
11. Two-color flow cytometric analysis of CD34-positive peripheral blood stem cells mobilized by recombinant human granulocyte-colony stimulating factor for autotransplantation.
Inaba T; Shimazaki C; Ashihara E; Ohkawa K; Oku N; Gotoh H; Fujita N; Tsuji H; Nakagawa M
Prog Clin Biol Res; 1992; 377():561-7. PubMed ID: 1279725
[No Abstract] [Full Text] [Related]
12. Expansion of neutrophil precursors and progenitors in suspension cultures of CD34+ cells enriched from human bone marrow.
Smith SL; Bender JG; Maples PB; Unverzagt K; Schilling M; Lum L; Williams S; Van Epps DE
Exp Hematol; 1993 Jul; 21(7):870-7. PubMed ID: 7686502
[TBL] [Abstract][Full Text] [Related]
13. Engagement of CD33 surface molecules prevents the generation of dendritic cells from both monocytes and CD34+ myeloid precursors.
Ferlazzo G; Spaggiari GM; Semino C; Melioli G; Moretta L
Eur J Immunol; 2000 Mar; 30(3):827-33. PubMed ID: 10741398
[TBL] [Abstract][Full Text] [Related]
14. Impact of the degree of maturation and differentiation of CD34+ cells in grafts of different origin on the duration of aplasia.
Wunder E; Sovalat H; Liang H; Becker M; Henon P
Prog Clin Biol Res; 1994; 389():345-50. PubMed ID: 7535441
[No Abstract] [Full Text] [Related]
15. Characterization of peripheral blood progenitor cells mobilized by nartograstim (N-terminal replaced granulocyte colony-stimulating factor) in normal volunteers.
Maruyama K; Tsuji K; Tanaka R; Yamada K; Kodera Y; Nakahata T
Bone Marrow Transplant; 1998 Aug; 22(4):313-20. PubMed ID: 9722064
[TBL] [Abstract][Full Text] [Related]
16. Enrichment of G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation by negative selection.
Dreger P; Steinmann J; Drost R; Eckstein V; Suttorp M; Müller-Ruchholtz W; Löffler H; Schmitz N
Prog Clin Biol Res; 1994; 389():407-13. PubMed ID: 7535449
[No Abstract] [Full Text] [Related]
17. Characterization of CD34+ cells mobilized to the peripheral blood during the recovery from cyclophosphamide chemotherapy.
Bender JG; Unverzagt KL; Walker DE; Lee W; Lum L; Van Epps DE; Williams SF; To LB
Prog Clin Biol Res; 1992; 377():575-82. PubMed ID: 1279727
[No Abstract] [Full Text] [Related]
18. Quality control for peripheral stem cell collection: the Ottawa experience.
Giulivi A; Huebsch LB; Van der Jagt R; Markman S; Fuller V; Birch P; Demone J; McDiermid S; Rutherford B
Prog Clin Biol Res; 1994; 389():753-9. PubMed ID: 7535465
[No Abstract] [Full Text] [Related]
19. Expansion of human umbilical cord blood CD34+ hematopoietic progenitor cells with recombinant growth factors.
Akabutu JJ; Chan JR
Prog Clin Biol Res; 1994; 389():399-404. PubMed ID: 7535448
[No Abstract] [Full Text] [Related]
20. Functional differences between subpopulations of mobilized peripheral blood-derived CD34+ cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens.
Sakabe H; Ohmizono Y; Tanimukai S; Kimura T; Mori KJ; Abe T; Sonoda Y
Stem Cells; 1997; 15(1):73-81. PubMed ID: 9007225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
